drugset / Trial / NCT00334386

Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.

NCT00334386

Phase 4 Completed 388 enrolled Ferrer Internacional S.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

Primary objective:To demonstrate the no-inferiority in efficacy of treatment with Torsemide-PR in relation to Torsemide-IR in patients with mild and/or moderate hypertension. Secondary objectives: To evaluate the safety and tolerability of Torsemide-PR.

Timeline

Start
2005-04
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Torasemide Unknown

Indications